TAE-1

CAS No. 1414469-59-2

TAE-1( —— )

Catalog No. M23568 CAS No. 1414469-59-2

TAE-1 is an inhibitor of amyloid-β fibril formation and aggregation. It inhibits cholinesterases AChE and BuChE with IC50 of 0.3 μM and 3.9 μM, respectively.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG 50 In Stock
50MG 86 In Stock
100MG 127 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    TAE-1
  • Note
    Research use only, not for human use.
  • Brief Description
    TAE-1 is an inhibitor of amyloid-β fibril formation and aggregation. It inhibits cholinesterases AChE and BuChE with IC50 of 0.3 μM and 3.9 μM, respectively.
  • Description
    TAE-1 is an inhibitor of amyloid-β fibril formation and aggregation. It inhibits cholinesterases AChE and BuChE with IC50 of 0.3 μM and 3.9 μM, respectively.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Endocrinology/Hormones
  • Target
    AChR
  • Recptor
    AChE|amyloid-β
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1414469-59-2
  • Formula Weight
    1128.57
  • Molecular Formula
    C39H51I3N6O9
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:10 mM
  • SMILES
    C[N+](C)(C)CCOC(=O)C1=CC=C(C=C1)OC2=NC(=NC(=N2)OC3=CC=C(C=C3)C(=O)OCC[N+](C)(C)C)OC4=CC=C(C=C4)C(=O)OCC[N+](C)(C)C.[I-].[I-].[I-]
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Biological activity of sym-triazines with acetylcholine-like substitutions as multitarget modulators of Alzheimer's disease.[J]. Acs Chemical Neuroscience, 2013, 4(6):924-9.
molnova catalog
related products
  • ATPO

    ATPO is Competitive antagonist at GluR1-4 (AMPA-preferring) receptors.

  • W-84 dibromide

    W-84 dibromide is a M2-receptor selective modulator.

  • Tropicamide

    Tropicamide is an anticholinergic and a Muscarinic Receptor subtype M4-preferring antagonist .